Caris Life Sciences Announces $100 Million Share Buyback Program
Caris Life Sciences (NASDAQ: CAI) has authorized a share repurchase program of up to $100 million. The announcement led to a premarket rise in the company's shares by 3.2%. This move is expected to signal confidence in its financial position and potentially boost shareholder value.
Topics: share buyback stock price movement